newsfilter
← Latest News
GlobeNewswire·

NightHawk Biosciences Provides Q1 2023 Business Update

DURHAM, N.C., May 15, 2023 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE:NHWK), a fully integrated biopharmaceutical company specializing in the end-to-end development, manufacturing, and commercialization of